PATENT CLAIM ANALYSIS

Application Number: 15887388
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "357000"]

Abstract:
The present disclosure relates to a pharmaceutical composition comprising as active substance betahistine or a pharmaceutically acceptable salt thereof, for use in the treatment of otological or neurological disorders in a human subject by intranasal application.

Claim (Index 65):
The pharmaceutical composition of  claim 60 , wherein the betahistine or a pharmaceutically acceptable salt thereof is selected from the group consisting of betahistine free base, betahistine hydrochloride, betahistine dihydrochloride, betahistine fumarate, betahistine maleate, betahistine tartrate, betahistine citrate, betahistine succinate, betahistine phthalate and betahistine mesylate.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 88.0
- Lexical Diversity: 1.11765
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13747367', '14966301', '12221333', '15866787', '15564824']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.818954627554829
- 35 USC 102 Novelty (BERT): 0.5217589130440212
- Combined Prediction Score: 0.7892350561037482
- Mean Citation Score: 280.87664200000006
- Max Citation Score: 304.8288
- Similarity Product: 174.44573279342652

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test